Breast cancer, Head and neck cancers, Hypopharyngeal cancer, Kidney cancer, Laryngeal cancer, Lung cancer, Mouth and oropharyngeal cancer, Non small cell lung cancer (NSCLC), Transitional cell cancer, Urothelial cancer (transitional cell cancer)
Open
Phase 1/2
This trial is looking at a new drug called KJ-103 by itself and in combination with pembrolizumab for cancer that has spread.
It is open to people with one of the following:
a of the head and neck
breast cancer
non small cell lung cancer
a type of kidney cancer called urothelial cancer
Cancer Research UK supports this trial.
Recruitment start: 29 May 2026
Recruitment end: 30 June 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Christian Ottensmeier
Cancer Research UK (CDD)
This is Cancer Research UK trial number CRUKD/26/001.
Last reviewed: 04 Jun 2026
CRUK internal database number: 20117
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
